Drug Profile
BBV 121
Alternative Names: BBV-121; Inactivated Zika virus vaccine; Zika virus vaccine - Bharat Biotech; ZIKAVACLatest Information Update: 29 Jul 2020
Price :
$50
*
At a glance
- Originator Bharat Biotech
- Class Antivirals; Zika virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Zika virus infection
Most Recent Events
- 21 Jul 2020 No recent reports of clinical development identified for Zika virus infections in India (IM)
- 17 Sep 2018 Bharat Biotech completes enrolment in its phase I trial for Zika virus infection (In volunteers) in India before September 2018 (CTRI2017-05-008539)